This unit of study will cover the therapeutics of immunology and cancer including the pharmaceutical sciences that underpin such drug therapies. This unit will also include the epidemiology, pathophysiology and clinical features of immunology and cancer. Through the use of case-based learning, students will participate in the interpretation, application and dissemination of pharmaceutical and pharmacotherapeutic concepts and knowledge. On completion of this unit of study students will be able to apply an understanding of the pharmaceutical sciences to optimising the drug and non-drug therapy of patients with cancer and immunological disorders. Interprofessional communication and the application of specialist knowledge to implementing pharmacist cognitive services such as clinical interventions and/or medication management review will also be explored. Students will become familiar with drug information software and a number of computerised drug information databases. Role-plays will be used to develop students' communication skills for interaction between pharmacists and their clients (patients, doctors, other health professionals).
1x4hr lecture/wk, 1x3hr workshop/wk
2hr written exam (60%), OSCE (25%), workshop participation (15%)
Walker, R. and Whittlesea, C. (2012). Clinical Pharmacy and Therapeutics (5th Ed) Australian Medicines Handbook eTG complete [provided as electronic resource] Lemke, TL and Williams, DA. (2013). Foye's Principles of Medicinal Chemistry (7th ed). Williams and Wilkins Rang, H.P., Dale, M.M., Ritter, J.M., Flower, R.J., Henderson, G. (2016). Rang and Dale's Pharmacology (8th ed)
(PHAR5711 or PHAR5911) and PHAR5712 and PHAR5713 and PHAR5714 and PHAR5715 and PHAR5716 and PHAR5717 and PHAR5718Co-requisites
PHAR5721 and PHAR5722 and PHAR5920